Nasdaq · Common stock
NewAmsterdam Pharma Company (NAMS)
$19.53 −$0.18 (−0.91%)
- Day’s range
- $19.27–$19.98
- Volume
- 1.6M
NAMS price history
NAMS closed at $19.53 on Oct. 26, 2026. Over the past year, its daily close ranged from $19.53 on Oct. 26, 2026 to $41.45 on Nov. 26, 2025.
Data table: NAMS daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $19.53 |
| Oct. 23, 2026 | $19.71 |
| Oct. 22, 2026 | $21.58 |
| Oct. 21, 2026 | $21.49 |
| Oct. 20, 2026 | $21.50 |
| Oct. 19, 2026 | $20.47 |
| Oct. 16, 2026 | $19.83 |
| Oct. 15, 2026 | $20.62 |
| Oct. 14, 2026 | $20.01 |
| Oct. 13, 2026 | $20.19 |
| Oct. 12, 2026 | $21.25 |
| Oct. 9, 2026 | $21.58 |
| Oct. 8, 2026 | $21.26 |
| Oct. 7, 2026 | $22.13 |
| Oct. 6, 2026 | $22.27 |
| Oct. 5, 2026 | $22.80 |
| Oct. 2, 2026 | $23.20 |
| Oct. 1, 2026 | $24.16 |
| Sept. 30, 2026 | $24.32 |
| Sept. 29, 2026 | $23.81 |
| Sept. 28, 2026 | $23.58 |
| Sept. 25, 2026 | $22.58 |
| Sept. 24, 2026 | $22.74 |
| Sept. 23, 2026 | $22.68 |
| Sept. 22, 2026 | $23.32 |
| Sept. 21, 2026 | $22.58 |
| Sept. 18, 2026 | $22.49 |
| Sept. 17, 2026 | $21.93 |
| Sept. 16, 2026 | $21.18 |
| Sept. 15, 2026 | $21.16 |
| Sept. 14, 2026 | $22.36 |
| Sept. 11, 2026 | $22.80 |
| Sept. 10, 2026 | $21.86 |
| Sept. 9, 2026 | $22.79 |
| Sept. 8, 2026 | $25.63 |
| Sept. 4, 2026 | $25.40 |
| Sept. 3, 2026 | $25.85 |
| Sept. 2, 2026 | $25.59 |
| Sept. 1, 2026 | $24.92 |
| Aug. 31, 2026 | $25.34 |
| Aug. 28, 2026 | $25.90 |
| Aug. 27, 2026 | $26.79 |
| Aug. 26, 2026 | $27.40 |
| Aug. 25, 2026 | $27.34 |
| Aug. 24, 2026 | $26.85 |
| Aug. 21, 2026 | $27.87 |
| Aug. 20, 2026 | $27.78 |
| Aug. 19, 2026 | $28.53 |
| Aug. 18, 2026 | $27.25 |
| Aug. 17, 2026 | $26.90 |
| Aug. 14, 2026 | $26.98 |
| Aug. 13, 2026 | $26.67 |
| Aug. 12, 2026 | $27.83 |
| Aug. 11, 2026 | $27.62 |
| Aug. 10, 2026 | $27.98 |
| Aug. 7, 2026 | $27.96 |
| Aug. 6, 2026 | $27.67 |
| Aug. 5, 2026 | $27.42 |
| Aug. 4, 2026 | $27.55 |
| Aug. 3, 2026 | $27.49 |
| July 31, 2026 | $27.79 |
| July 30, 2026 | $28.46 |
| July 29, 2026 | $27.91 |
| July 28, 2026 | $27.98 |
| July 27, 2026 | $30.22 |
| July 24, 2026 | $29.64 |
| July 23, 2026 | $30.55 |
| July 22, 2026 | $31.70 |
| July 21, 2026 | $32.34 |
| July 20, 2026 | $29.67 |
| July 17, 2026 | $31.68 |
| July 16, 2026 | $31.05 |
| July 15, 2026 | $31.98 |
| July 14, 2026 | $33.29 |
| July 13, 2026 | $33.28 |
| July 10, 2026 | $35.26 |
| July 9, 2026 | $35.92 |
| July 8, 2026 | $35.83 |
| July 7, 2026 | $36.99 |
| July 6, 2026 | $34.90 |
| July 2, 2026 | $34.83 |
| July 1, 2026 | $35.17 |
| June 30, 2026 | $33.89 |
| June 29, 2026 | $33.87 |
| June 26, 2026 | $33.24 |
| June 25, 2026 | $31.73 |
| June 24, 2026 | $32.63 |
| June 23, 2026 | $31.40 |
| June 22, 2026 | $30.82 |
| June 18, 2026 | $29.83 |
| June 17, 2026 | $30.15 |
| June 16, 2026 | $30.19 |
| June 15, 2026 | $30.60 |
| June 12, 2026 | $30.40 |
| June 11, 2026 | $30.26 |
| June 10, 2026 | $29.33 |
| June 9, 2026 | $30.38 |
| June 8, 2026 | $30.95 |
| June 5, 2026 | $31.52 |
| June 4, 2026 | $32.67 |
| June 3, 2026 | $32.11 |
| June 2, 2026 | $31.71 |
| June 1, 2026 | $31.79 |
| May 29, 2026 | $33.68 |
| May 28, 2026 | $35.42 |
| May 27, 2026 | $36.56 |
| May 26, 2026 | $36.11 |
| May 22, 2026 | $35.44 |
| May 21, 2026 | $35.74 |
| May 20, 2026 | $35.75 |
| May 19, 2026 | $33.72 |
| May 18, 2026 | $34.14 |
| May 15, 2026 | $35.44 |
| May 14, 2026 | $36.88 |
| May 13, 2026 | $37.75 |
| May 12, 2026 | $38.89 |
| May 11, 2026 | $39.59 |
| May 8, 2026 | $38.73 |
| May 7, 2026 | $34.85 |
| May 6, 2026 | $30.99 |
| May 5, 2026 | $29.85 |
| May 4, 2026 | $29.86 |
| May 1, 2026 | $28.43 |
| April 30, 2026 | $28.56 |
| April 29, 2026 | $28.43 |
| April 28, 2026 | $28.72 |
| April 27, 2026 | $30.45 |
| April 24, 2026 | $29.72 |
| April 23, 2026 | $31.46 |
| April 22, 2026 | $31.94 |
| April 21, 2026 | $32.48 |
| April 20, 2026 | $33.82 |
| April 17, 2026 | $34.68 |
| April 16, 2026 | $33.20 |
| April 15, 2026 | $34.01 |
| April 14, 2026 | $34.44 |
| April 13, 2026 | $36.25 |
| April 10, 2026 | $34.76 |
| April 9, 2026 | $35.07 |
| April 8, 2026 | $34.01 |
| April 7, 2026 | $33.91 |
| April 6, 2026 | $34.12 |
| April 2, 2026 | $32.99 |
| April 1, 2026 | $32.81 |
| March 31, 2026 | $32.01 |
| March 30, 2026 | $29.33 |
| March 27, 2026 | $29.98 |
| March 26, 2026 | $31.25 |
| March 25, 2026 | $31.01 |
| March 24, 2026 | $30.06 |
| March 23, 2026 | $30.01 |
| March 20, 2026 | $28.94 |
| March 19, 2026 | $30.46 |
| March 18, 2026 | $29.44 |
| March 17, 2026 | $30.60 |
| March 16, 2026 | $29.79 |
| March 13, 2026 | $28.62 |
| March 12, 2026 | $29.82 |
| March 11, 2026 | $31.35 |
| March 10, 2026 | $31.27 |
| March 9, 2026 | $30.77 |
| March 6, 2026 | $29.86 |
| March 5, 2026 | $30.14 |
| March 4, 2026 | $31.18 |
| March 3, 2026 | $30.41 |
| March 2, 2026 | $32.83 |
| Feb. 27, 2026 | $35.46 |
| Feb. 26, 2026 | $34.28 |
| Feb. 25, 2026 | $35.01 |
| Feb. 24, 2026 | $36.01 |
| Feb. 23, 2026 | $36.17 |
| Feb. 20, 2026 | $35.58 |
| Feb. 19, 2026 | $34.63 |
| Feb. 18, 2026 | $35.76 |
| Feb. 17, 2026 | $35.24 |
| Feb. 13, 2026 | $34.63 |
| Feb. 12, 2026 | $34.86 |
| Feb. 11, 2026 | $34.24 |
| Feb. 10, 2026 | $34.89 |
| Feb. 9, 2026 | $35.00 |
| Feb. 6, 2026 | $34.30 |
| Feb. 5, 2026 | $32.06 |
| Feb. 4, 2026 | $32.98 |
| Feb. 3, 2026 | $32.99 |
| Feb. 2, 2026 | $31.57 |
| Jan. 30, 2026 | $31.12 |
| Jan. 29, 2026 | $31.44 |
| Jan. 28, 2026 | $31.88 |
| Jan. 27, 2026 | $32.63 |
| Jan. 26, 2026 | $32.37 |
| Jan. 23, 2026 | $33.32 |
| Jan. 22, 2026 | $34.81 |
| Jan. 21, 2026 | $33.94 |
| Jan. 20, 2026 | $32.41 |
| Jan. 16, 2026 | $31.65 |
| Jan. 15, 2026 | $31.83 |
| Jan. 14, 2026 | $31.92 |
| Jan. 13, 2026 | $31.86 |
| Jan. 12, 2026 | $32.69 |
| Jan. 9, 2026 | $34.37 |
| Jan. 8, 2026 | $35.80 |
| Jan. 7, 2026 | $35.45 |
| Jan. 6, 2026 | $34.02 |
| Jan. 5, 2026 | $33.48 |
| Jan. 2, 2026 | $35.20 |
| Dec. 31, 2025 | $35.08 |
| Dec. 30, 2025 | $34.74 |
| Dec. 29, 2025 | $35.02 |
| Dec. 26, 2025 | $35.27 |
| Dec. 24, 2025 | $35.65 |
| Dec. 23, 2025 | $35.95 |
| Dec. 22, 2025 | $36.49 |
| Dec. 19, 2025 | $35.11 |
| Dec. 18, 2025 | $33.90 |
| Dec. 17, 2025 | $33.68 |
| Dec. 16, 2025 | $34.22 |
| Dec. 15, 2025 | $35.35 |
| Dec. 12, 2025 | $37.25 |
| Dec. 11, 2025 | $36.17 |
| Dec. 10, 2025 | $35.61 |
| Dec. 9, 2025 | $34.80 |
| Dec. 8, 2025 | $35.75 |
| Dec. 5, 2025 | $35.26 |
| Dec. 4, 2025 | $35.85 |
| Dec. 3, 2025 | $35.52 |
| Dec. 2, 2025 | $38.33 |
| Dec. 1, 2025 | $39.61 |
| Nov. 28, 2025 | $41.30 |
| Nov. 26, 2025 | $41.45 |
| Nov. 25, 2025 | $40.44 |
| Nov. 24, 2025 | $39.31 |
| Nov. 21, 2025 | $38.27 |
| Nov. 20, 2025 | $37.71 |
| Nov. 19, 2025 | $38.62 |
| Nov. 18, 2025 | $38.91 |
| Nov. 17, 2025 | $38.56 |
| Nov. 14, 2025 | $38.35 |
| Nov. 13, 2025 | $36.42 |
| Nov. 12, 2025 | $38.31 |
| Nov. 11, 2025 | $39.89 |
| Nov. 10, 2025 | $38.97 |
| Nov. 7, 2025 | $36.76 |
| Nov. 6, 2025 | $37.05 |
| Nov. 5, 2025 | $38.13 |
| Nov. 4, 2025 | $36.53 |
| Nov. 3, 2025 | $37.00 |
| Oct. 31, 2025 | $37.95 |
| Oct. 30, 2025 | $38.72 |
| Oct. 29, 2025 | $35.84 |
| Oct. 28, 2025 | $36.14 |
| Oct. 27, 2025 | $36.04 |
Key figures
- 52-week range
- $19.53–$41.45Low Oct. 26, 2026; high Nov. 26, 2025
- Average daily volume
- 1.5MPast 3 months
- Market value
- $2.33B
- Dividend yield
- —
- From 52-week high
- −52.88%
Price change
- 1 month
- −13.51%
- 3 months
- −34.11%
- Year to date
- −44.33%
- 1 year
- −45.32%
$1,000 a year ago
$1,000 put into NAMS at the close on Oct. 24, 2025 would be worth $547.
Price only, dividends not included.
What Wall Street says about NAMS
In the past 90 days, Wall Street firms published 3 rating or price-target actions on NAMS: 1 reiterated rating and 2 lowered price targets.
| Action | Rating | |||
|---|---|---|---|---|
| RBC Capital | Cuts target | Outperform | $50 to $42 | |
| HC Wainwright & Co. | Reiterates | Buy | $52 | |
| RBC Capital | Cuts target | Outperform | $51 to $50 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
- Headquarters
- Narrden
- Employees
- 100
- Listed
- Nov. 23, 2022
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about NAMS is on the site yet.